skip to navigation skip to content

Women biotech leaders


Dr Rebecca Myers of the Entrepreneurship Centre at Cambridge Judge is included in the Movers and Shakers in BioBusiness 2020 report by the BioBeat project. 

Biotech 883 x 432

Dr Rebecca Myers, Head of Education at the Entrepreneurship Centre of Cambridge Judge Business School, has been included in the Movers and Shakers in BioBusiness 2020 report issued by BioBeat, a Cambridge-based project that connects entrepreneurs with biotech leaders. 

This year’s report revolves around the theme ‘Connecting for Strength’ and showcases 30 women biotech leaders in five categories: Science & Technology, Finance, Collaboration, Patient Impact and Infrastructure. Rebecca was chosen in the Infrastructure category, which is based on ‘Supporting innovation from concept to market’.

The report says: “Educating the next generation of scientific innovators Rebecca designed the EnterpriseTECH and EnterpriseTECH STAR talent-development and early-stage commercialisation pipelines to help scientists transform inventions into business opportunities. More than 140 PhD and postdoctoral researchers have already come through the programmes, which equip participants to increase their capacity for generating ideas and build the skills to make them happen.”

This year’s report also includes other Cambridge Judge connections: the Movers & Shakers in the Science & Technology category include Hannah Sore, Founder and CEO of PharmEnable, a life sciences company currently on the Accelerate Cambridge programme of the Entrepreneurship Centre; the Movers & Shakers in the Patient Impact category include Lucy Jung, CEO and Co-founder of Charco Neurotech, a firm focusing on Parkinson’s disease that is on Accelerate Cambridge, and Shardi Nahavandi, CEO and Founder of data-driven female healthcare firm Pexxi, which was previously on Accelerate Cambridge. The Science and Technology Alumni section of the report includes Myriam Ouberai, CEO and Founder of cancer treatment firm Spirea, which is also on Accelerate Cambridge.

BioBeat was founded in 2012 by biotech consultant Miranda Weston-Smith, co-founder of the Cambridge Network.

“It is the strength in our human connections that enables entrepreneurs and researchers to bring ideas to life,” she said in announcing this year’s report. “The COVID-19 pandemic has brought out the very best of British science, highlighting the resilience of the sector and our capacity for collaboration and innovation.”

The Movers and Shakers in BioBusiness 2020 report was released in advance of the BioBeat20 Summit: Accelerating data-driven health, which will be held online this year on Tuesday 17 November in partnership with the Francis Crick Institute. Other partners of BioBeat and the Movers and Shakers report include the Entrepreneurship Centre at Cambridge Judge, AstraZeneca, Appleyard Lees, Covington & Burling, the Innovation Forum and One Nucleus.